ENXTAM:DSM

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. More Details


Snowflake Analysis

Excellent balance sheet second-rate dividend payer.


Similar Companies

Share Price & News

How has Koninklijke DSM's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: DSM is less volatile than 75% of Dutch stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: DSM's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

1.9%

DSM

0.7%

NL Chemicals

-0.8%

NL Market


1 Year Return

41.9%

DSM

37.4%

NL Chemicals

40.4%

NL Market

Return vs Industry: DSM exceeded the Dutch Chemicals industry which returned 26.9% over the past year.

Return vs Market: DSM exceeded the Dutch Market which returned 25.5% over the past year.


Shareholder returns

DSMIndustryMarket
7 Day1.9%0.7%-0.8%
30 Day-3.5%-1.8%1.5%
90 Day4.2%3.4%9.3%
1 Year44.8%41.9%40.4%37.4%43.0%40.4%
3 Year86.4%74.4%48.1%29.1%22.3%10.1%
5 Year233.4%194.7%131.7%88.8%65.8%35.2%

Long-Term Price Volatility Vs. Market

How volatile is Koninklijke DSM's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Koninklijke DSM undervalued compared to its fair value and its price relative to the market?

54.5x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: DSM (€142.35) is trading above our estimate of fair value (€113.92)

Significantly Below Fair Value: DSM is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: DSM is poor value based on its PE Ratio (54.5x) compared to the NL Chemicals industry average (26x).

PE vs Market: DSM is poor value based on its PE Ratio (54.5x) compared to the Dutch market (26x).


Price to Earnings Growth Ratio

PEG Ratio: DSM is poor value based on its PEG Ratio (3.3x)


Price to Book Ratio

PB vs Industry: DSM is overvalued based on its PB Ratio (3.3x) compared to the NL Chemicals industry average (3x).


Next Steps

Future Growth

How is Koninklijke DSM forecast to perform in the next 1 to 3 years based on estimates from 22 analysts?

16.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DSM's forecast earnings growth (16.7% per year) is above the savings rate (0.2%).

Earnings vs Market: DSM's earnings (16.7% per year) are forecast to grow slower than the Dutch market (26.5% per year).

High Growth Earnings: DSM's earnings are forecast to grow, but not significantly.

Revenue vs Market: DSM's revenue (5.3% per year) is forecast to grow slower than the Dutch market (10.2% per year).

High Growth Revenue: DSM's revenue (5.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DSM's Return on Equity is forecast to be low in 3 years time (12.3%).


Next Steps

Past Performance

How has Koninklijke DSM performed over the past 5 years?

3.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DSM has high quality earnings.

Growing Profit Margin: DSM's current net profit margins (5.5%) are lower than last year (8.4%).


Past Earnings Growth Analysis

Earnings Trend: DSM's earnings have grown by 3.7% per year over the past 5 years.

Accelerating Growth: DSM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DSM had negative earnings growth (-33.7%) over the past year, making it difficult to compare to the Chemicals industry average (7%).


Return on Equity

High ROE: DSM's Return on Equity (6.1%) is considered low.


Next Steps

Financial Health

How is Koninklijke DSM's financial position?


Financial Position Analysis

Short Term Liabilities: DSM's short term assets (€5.4B) exceed its short term liabilities (€2.3B).

Long Term Liabilities: DSM's short term assets (€5.4B) exceed its long term liabilities (€4.6B).


Debt to Equity History and Analysis

Debt Level: DSM's debt to equity ratio (45.1%) is considered high.

Reducing Debt: DSM's debt to equity ratio has reduced from 53.5% to 45.1% over the past 5 years.

Debt Coverage: DSM's debt is well covered by operating cash flow (44.3%).

Interest Coverage: DSM's interest payments on its debt are well covered by EBIT (9.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Koninklijke DSM current dividend yield, its reliability and sustainability?

1.69%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: DSM's dividend (1.69%) isn’t notable compared to the bottom 25% of dividend payers in the Dutch market (1.88%).

High Dividend: DSM's dividend (1.69%) is low compared to the top 25% of dividend payers in the Dutch market (4.51%).


Stability and Growth of Payments

Stable Dividend: DSM's dividends per share have been stable in the past 10 years.

Growing Dividend: DSM's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (91.9%), DSM's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: DSM's dividends in 3 years are forecast to be well covered by earnings (46.3% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average management tenure


CEO

Dimitri de Vreeze (53 yo)

1.08yrs

Tenure

€2,639,000

Compensation

Mr. Dimitri de Vreeze serves as Chief Operating Officer of DSM Nutritional Products AG. He serves as President of DSM Resins at DSM-AGI Corporation. He has been a Member of Management Board at Koninklijke ...


CEO Compensation Analysis

Compensation vs Market: Dimitri's total compensation ($USD3.13M) is about average for companies of similar size in the Dutch market ($USD3.14M).

Compensation vs Earnings: Dimitri's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Dimitri de Vreeze
Co-CEO, COO & Member of the Managing Board1.08yrs€2.64m0.061%
€ 15.0m
Geraldine Matchett
Co-CEO, CFO & Member of the Managing Board1.08yrs€2.60m0.061%
€ 14.8m
Jos Heij
Senior VP of Corporate Control & Accounting and Group Controller8.58yrsno datano data
Marcus Remmers
Chief Technology Officer3.92yrsno datano data
Dave Huizing
Vice President of Investor Relations8.67yrsno datano data
Cees Los
Director of Legal Affairs and General Counsel8.92yrsno datano data
Lieke Jong-Tops
Senior Communications Managerno datano datano data
Cristina Monteiro
Executive Vice President of People & Organization0.50yrno datano data
Rob Atsma
Head of Energie Beheer Nederlandno datano datano data
Christoph Goppelsroeder
President & CEO of Nutritional Products8.17yrs€87.56kno data
Paul Gilgen
Head of Manufacturing & Purchasing of DSM Nutritional Productsno datano datano data
Manfred Eggersdorfer
Senior Vice President of Nutrition Science & Advocacyno datano datano data

6.0yrs

Average Tenure

64yo

Average Age

Experienced Management: DSM's management team is seasoned and experienced (6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frits van Paasschen
Independent Member of Supervisory Board3.83yrs€96.75kno data
Feike Sijbesma
Member of Sustainability Advisory Board & Honorary Chairman1yr€3.35m0.15%
€ 36.3m
Robert Routs
Independent Chairman of Supervisory Board9.92yrs€128.75kno data
John Ramsay
Independent Member of Supervisory Board3.83yrs€98.25k0.00061%
€ 149.5k
Pauline Francoise van der Meer Mohr
Independent Deputy Chairwoman of Supervisory Boardno data€98.75k0.00089%
€ 218.2k
Paul Gilding
Member of Sustainability Advisory Boardno datano datano data
David King
Member of Sustainability Advisory Boardno datano datano data
Eileen Kennedy
Independent Member of Supervisory Board8.83yrs€98.75kno data
Pradeep Pant
Independent Member of Supervisory Board4.92yrs€96.75kno data
Ye Qi
Member of Sustainability Advisory Boardno datano datano data
Ndidi Nwuneli
Member of Sustainability Advisory Board5.08yrsno datano data
Christopher Voigt
Member of Scientific Advisory Boardno datano datano data

4.9yrs

Average Tenure

63yo

Average Age

Experienced Board: DSM's board of directors are considered experienced (4.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Koninklijke DSM N.V.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Koninklijke DSM N.V.
  • Ticker: DSM
  • Exchange: ENXTAM
  • Founded: 1902
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: €24.515b
  • Shares outstanding: 172.22m
  • Website: https://www.dsm.com

Number of Employees


Location

  • Koninklijke DSM N.V.
  • Het Overloon 1
  • Heerlen
  • Limburg
  • 6411 TE
  • Netherlands

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DSMENXTAM (Euronext Amsterdam)YesOrdinary SharesNLEURJan 1992
DSM2DB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 1992
DSMBRSE (Berne Stock Exchange)YesOrdinary SharesCHCHFJan 1992
KDSK.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJan 1992
DSM2XTRA (XETRA Trading Platform)YesOrdinary SharesDEEURJan 1992
0NPPLSE (London Stock Exchange)YesOrdinary SharesGBEURJan 1992
DSMABATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURJan 1992
RDSMWBAG (Wiener Boerse AG)YesOrdinary SharesATEURJan 1992
DSM NBMV (Bolsa Mexicana de Valores)YesOrdinary SharesMXMXNJan 1992
RDSM.YOTCPK (Pink Sheets LLC)ADR-EACH 4 CNV INTO 1 ORD EUR1.5USUSDSep 1995
DSMDB (Deutsche Boerse AG)ADR-EACH 4 CNV INTO 1 ORD EUR1.5DEEURSep 1995

Biography

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/03/08 20:34
End of Day Share Price2021/03/08 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.